InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Newhall Charles W III, Director. Insider active across 1 company, notably Supernus Pharmaceuticals, INC.. In total, 13 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €1.3m. Activity tracked since 19 February 2022. The latest transaction was disclosed on 24 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Newhall Charles W III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
4,475 shares0Common StockSEC:0001005544-26-000004:0
15,000 shares@ US$12.989.7% of flowCommon StockSEC:0001628280-25-053877:0
23,800 shares@ US$50.730.037% mcap50.0% of flowCommon StockSEC:0001628280-25-044797:0
3,588 shares@ US$45.018.8% of flowCommon StockSEC:0001005544-25-000008:0
1,000 shares@ US$45.002.5% of flowCommon StockSEC:0001005544-25-000006:0
1,412 shares@ US$45.003.9% of flowCommon StockSEC:0001005544-25-000004:0
5,369 shares0Common StockSEC:0001628280-25-007476:0
20,000 shares@ US$9.137.1% of flowCommon StockSEC:0001628280-24-047155:0
3,886 shares0Common StockSEC:0001104659-24-028281:0
7,457 shares@ US$9.242.7% of flowCommon StockSEC:0001104659-23-119962:0
3,882 shares0Common StockSEC:0001104659-23-025374:0
8,722 shares@ US$7.902.7% of flowCommon StockSEC:0001104659-22-131398:0
4,222 shares0Common StockSEC:0001104659-22-026109:0
13 of 13 declarations
About Newhall Charles W III
Charles W. Newhall III is a Director of SUPERNUS PHARMACEUTICALS, INC. He plays a key role in the strategic direction of the company, ensuring that decisions made align with growth and innovation objectives.
